Brought to you by:
Silk Road to evaluate TCAR in standard surgical risk patients with ROADSTER 3 study
Silk Road Medical today announced a post-market study to evaluate the transcarotid artery revascularization (TCAR) system in the treatment of standard surgical risk patients with carotid artery disease. The ROADSTER 3 study will fulfill the US Food and Drug Administration’s…
Early TCAR results in higher ipsilateral postoperative stroke rates when compared to carotid endarterectomy
Adham Elmously, MD, a fellow at New York Presbyterian Hospital, New York, is set to present outcomes of early transcarotid artery revascularization (TCAR) vs. carotid endarterectomy (CEA) after acute neurologic events during the opening day of the Vascular Annual Meeting…
SVS has patient resources and guidelines on strokes
May was Stroke Awareness Month, and the Society for Vascular Surgery (SVS) and SVS Foundation offer educational resources for Society members to provide as a resource to their patients at risk of the potentially devastating disease no matter the time…
A new pathway for preventing dementia?
Craig Weinkauf, MD, is leading a trial looking into a connection between Alzheimer’s and carotid stenosis. ‘We want to try to quantify the brain: volumes, structural connectivity, functional connectivity and other relevant findings associated with neurodegeneration,’ he says. Society for…
Research indicates low stroke risk and benefit of medication alone in asymptomatic carotid stenosis
The risk of having a future stroke caused by asymptomatic carotid stenosis is “so low” that most patients with this condition could potentially be treated with the newest medications and may not require surgery. That is according to new research from Kaiser…
Expanded Medicare coverage for TCAR in standard surgical risk patients announced
Silk Road Medical today announced that the Centers for Medicare and Medicaid Services (CMS), through collaboration with the Society of Vascular Surgery’s Patient Safety Organization (SVS PSO) and their Vascular Quality Initiative (VQI), has expanded coverage for TCAR to include…
Silent coronary ischemia: FFRCT reduces cardiac death, myocardial infarction in carotid endarterectomy patients out to three years, study finds
Diagnosis of silent, or unsuspected, coronary ischemia in patients undergoing carotid endarterectomy (CEA) using fractional flow reserve-computed tomography (FFRCT), with selective postoperative coronary revascularization, significantly reduced cardiovascular death, cardiac death and myocardial infarction through three years of follow-up when compared…
ESVS publishes 2023 guidelines on management of atherosclerotic carotid and vertebral artery disease
The European Society for Vascular Surgery (ESVS) has just released 2023 clinical practice guidelines on the management of atherosclerotic carotid and vertebral artery disease. The guideline document, authored by chairperson Ross Naylor, MBChB, from Leicester Vascular Institute, Leicester, England, co-chairperson Barbara…
FDA approves expanded indications for TCAR’s Enroute stent
The Food and Drug Administration (FDA) approved expanded indications for the Enroute stent system—part of the transcarotid artery revascularization (TCAR) procedure—to include patients at standard risk for adverse events from carotid endarterectomy (CEA), Silk Road Medical announced today. Previously, the…
Increased market competition linked to higher odds of revascularization among asymptomatic patients with moderate carotid stenosis
A vascular surgery research team with a growing reputation for its work investigating appropriateness in care in the peripheral vascular bed recently uncovered an association between increased regional market competition among proceduralists and higher odds of revascularization being carried out…